Dr Joseph D Heineman, MD | |
38 Powel Ave, Newport, RI 02840-2655 | |
(401) 847-2418 | |
(401) 619-1028 |
Full Name | Dr Joseph D Heineman |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 30 Years |
Location | 38 Powel Ave, Newport, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154394096 | NPI | - | NPPES |
7008228 | Medicaid | RI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD10348 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Westerly Hospital | Westerly, RI | Hospital |
South County Hospital Inc | Wakefield, RI | Hospital |
The Miriam Hospital | Providence, RI | Hospital |
Newport Hospital | Newport, RI | Hospital |
Lawrence & Memorial Hospital | New london, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has released a new way to deliver the impulses of the ReBuilder for pain.
In metastatic renal cell carcinoma patients, there is no significant correlation between adverse event profiles of first- and second-line tyrosine kinase inhibitors, suggests a Japanese study.
The WHO's Stop TB Partnership "laid out a new plan on Wednesday to combat tuberculosis and the nearly 2 million deaths it causes each year," Reuters reports.
Since the coronavirus disease 2019 (COVID-19) outbreak was identified in Wuhan, China, in December 2019, many countries have introduced restrictive measures to curb the circulation and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
› Verified 6 days ago
Entity Name | Northeast Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20170518000594 |
News Archive
ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has released a new way to deliver the impulses of the ReBuilder for pain.
In metastatic renal cell carcinoma patients, there is no significant correlation between adverse event profiles of first- and second-line tyrosine kinase inhibitors, suggests a Japanese study.
The WHO's Stop TB Partnership "laid out a new plan on Wednesday to combat tuberculosis and the nearly 2 million deaths it causes each year," Reuters reports.
Since the coronavirus disease 2019 (COVID-19) outbreak was identified in Wuhan, China, in December 2019, many countries have introduced restrictive measures to curb the circulation and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joseph D Heineman, MD 38 Powel Ave, Newport, RI 02840-2655 Ph: (401) 847-2418 | Dr Joseph D Heineman, MD 38 Powel Ave, Newport, RI 02840-2655 Ph: (401) 847-2418 |
News Archive
ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has released a new way to deliver the impulses of the ReBuilder for pain.
In metastatic renal cell carcinoma patients, there is no significant correlation between adverse event profiles of first- and second-line tyrosine kinase inhibitors, suggests a Japanese study.
The WHO's Stop TB Partnership "laid out a new plan on Wednesday to combat tuberculosis and the nearly 2 million deaths it causes each year," Reuters reports.
Since the coronavirus disease 2019 (COVID-19) outbreak was identified in Wuhan, China, in December 2019, many countries have introduced restrictive measures to curb the circulation and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data on its investigational agent PV-10 for intralesional (IL) treatment of solid tumors were featured in two presentations in the Poster Highlights Session, Melanoma/Skin Cancers, on June 2, 2014 during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL.
› Verified 6 days ago
Dr. Richard Taylor Zuerner, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 38 Powel Ave, Newport, RI 02840 Phone: 401-847-2418 Fax: 401-619-1028 | |
Samuel Hamilton Eaton, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Powel Ave Apt 3, Newport, RI 02840 Phone: 401-228-0631 Fax: 401-324-5025 | |
Dr. Arnold A. Sarazen, M.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 38 Powel Ave, Newport, RI 02840 Phone: 401-847-2418 Fax: 401-619-1028 | |
Dr. John Philip Heffernan, M.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 38 Powel Ave, Newport, RI 02840 Phone: 401-847-2418 Fax: 401-619-1028 |